Table 1 Clinical features of SCLC patients
From: Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer
Characteristics | All patients (N = 53) (%) |
|---|---|
Age | 60 |
< 60 | 25 (47.2) |
≥ 60 | 28 (52.8) |
Gender | |
Male | 4 9 (92.5) |
Female | 4 (7.5) |
Clinical Stages | |
Limited stage | 24 (45.3) |
Extensive stage | 29 (54.7) |
Smoking | |
Never smoker | 11 (20.8) |
Smoker | 42 (79.2) |
ECOG PS Score | |
0 | 5 (9.4) |
1 | 41 (77.4) |
2 | 7 (13.2) |
Past Medical History, NO (%) | |
Cardiopathy | 1 (1.9) |
Diabetes | 2 (3.8) |
Hypertension | 11 (20.8) |
Hypertension & Diabetes | 2 (3.8) |
Respiratory Disease | 3 (5.7) |
None | 34 (64.2) |
Radiotherapy | |
Yes | 35 (66.0) |
No | 18 (34.0) |